CYTOKINETICS INC
For the period ended Mar 31, 2025. Filed May 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 6, 2025
CYTK$55.14+2.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
(In thousands) (Unaudited)
| March 31, 2025 | December 31, 2024 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $73,680 | $94,857 |
| Short-term investments | 864,538 | 981,157 |
| Accounts receivable | 2,012 | 16,650 |
| Prepaid expenses and other current assets | 15,823 | 15,276 |
| Total current assets | 956,053 | 1,107,940 |
| Long-term investments | 150,687 | 145,055 |
| Property and equipment, net | 67,175 | 65,815 |
| Operating lease right-of-use assets | 77,439 | 75,158 |
| Other assets | 12,697 | 7,705 |
| Total assets | $1,264,051 | $1,401,673 |
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||
| Current liabilities: | ||
| Accounts payable | $13,942 | $20,369 |
| Accrued liabilities | 43,358 | 55,323 |
| Short-term operating lease liabilities | 19,574 | 18,978 |
| Current portion of long-term debt | 12,960 | 11,520 |
| Derivative liabilities measured at fair value | 11,700 | 11,300 |
| Deferred revenue | 52,370 | 52,370 |
| Other current liabilities | 5,822 | 9,814 |
| Total current liabilities | 159,726 | 179,674 |
| Term loans, net | 92,025 | 93,227 |
| Convertible notes, net | 553,143 | 552,370 |
| Liabilities related to revenue participation right purchase agreements, net | 476,296 | 462,192 |
| Long-term operating lease liabilities | 113,353 | 112,582 |
| Liabilities related to RPI Transactions measured at fair value | 133,100 | 137,000 |
| Other non-current liabilities | 2,821 | — |
| Total liabilities | 1,530,464 | 1,537,045 |
| Commitments and contingencies | ||
| Stockholders' deficit | ||
| Preferred stock | — | — |
| Common stock | 119 | 118 |
| Additional paid-in capital | 2,595,063 | 2,563,876 |
| Accumulated other comprehensive income | 1,545 | 2,398 |
| Accumulated deficit | (2,863,140) | (2,701,764) |
| Total stockholders' deficit | (266,413) | (135,372) |
| Total liabilities and stockholders' deficit | $1,264,051 | $1,401,673 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.